Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Marine and fisheries research, and Marine and coastal plant biology.
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)
Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer
Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD
Biodiversity influences the effects of oil disturbance on coastal ecosystems.
A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease
Adaptive immunity induces mutualism between commensal eukaryotes
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease
Complexities of disturbance response in a marine food web
Herbivory in Seagrass Meadows: an Evolving Paradigm
501 Trial in progress: VALO study evaluating PTX-022 in adults with moderate-to-severe pachyonychia congenita, a rare, chronically debilitating disease that makes walking difficult or impossible
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis
Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome
Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohnʼs Disease
Briakinumab for Treatment of Crohnʼs Disease
MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis
Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
Contribution of higher risk genes and European admixture to Crohnʼs disease in African Americans